What is new in the world of bio when it comes to small cap? So far though the company has remained somewhat balanced. Seeing an investment that controls nearly 20% of outstanding shares is impressive in one way, but dangerously controlling in another.
What is liked about this company approach is that I feel this method is not just locked into the flu virus, but has unlimited uses. I can see this approach used in attacking the AIDS virus, but very uncertain why others have not tried this approach. Maybe someone has already? The superbugs are on their way none the less.
One must remind themselves. This approach is not an anti biotic, but a true vaccine with alternating pathways. To me it sounds like this company will be in the forefront of a trending superbug exposure. I do not intend to mislead on my opinion, but my imagination is hard working this morning.
News 
Market Data 
Discover 
